Medindia

X

Connectyx Technologies Signs Marketing Agreement with Hereditary Neuropathy Foundation

Wednesday, June 9, 2010 Corporate News J E 4
Advertisement


PALM CITY, Fla., June 9 Connectyx Technologies Holdings Group Inc. (OTCPK: CTYX) is pleased to announce that the Company has signed a marketing agreement with the Hereditary Neuropathy Foundation (HNF), a non-profit organization that focuses on raising awareness, funding scientific research, and educating the medical community as well as the general public about Charcot-Marie Tooth disease (CMT). HNF offers people with CMT, and their families, medical information and emotional support. The agreement will allow Connectyx to promote its MedFlash® Personal Health manager directly to Hereditary Neuropathy Foundation's membership and their families, through HNF's membership benefit program located on their web site.

Charcot-Marie-Tooth disease (CMT) is a hereditary motor-sensory neuropathy (HMSN). HMSNs are a group of progressive neurological disorders that affect the motor and sensory units of the peripheral nervous system. CMT causes weakness because the nerve signals are impaired (demyelinated) before they reach the muscle. Over time this causes atrophy (a loss of muscle strength) in various areas of the body such as the feet, legs, hands, and diaphragm. CMT is considered to be the most commonly inherited form of peripheral neuropathy affecting approximately one in 2,500 adults. CMT is diagnosed by clinical features of muscle atrophy, age of onset, electromyography (EMG), nerve biopsy and through genetic testing.

Allison Moore, Founder & President of the Hereditary Neuropathy Foundation, understands the importance of having one's medical history with them at all times. Allison's father had CMT but she had virtually no symptoms of CMT until she was mistakenly given a drug that caused her to have a severe onset of CMT symptoms including gait imbalance, muscle weakness and severe fatigue. "HNF is thrilled to become a strategic partner of MedFlash. It is critical that CMT patients carry with them at all times a list of neurotoxic drugs to avoid potentially debilitating or even lethal side effects from contraindicated drug treatments. Furthermore, when dealing with a genetic neurological disease like CMT, family history is critical to diagnosis and treatment. It can not only prevent medical catastrophes but also reduce unnecessary testing to obtain a diagnosis. "

HNF promotes and supports both clinical and primary CMT research. The foundation is also actively committed to increasing awareness of the disease through all available media outlets, including print, radio and television as well as fundraising programs. While HNF members give a face to CMT, the foundation provides a strong, organizational voice to those living with CMT all over the world. HNF continues to educate physicians, along with the entire medical community, about CMT. They are a critical source of information for the general public about this important, often misunderstood disease.

"We are excited about the relationship with the Hereditary Neuropathy Foundation. The MedFlash Personal Health Manager will be a valuable tool for their members," stated Ronn Schuman, President and CEO of Connectyx Technologies Holdings Group, Inc.

For more information about Hereditary Neuropathy Foundation, please visit: www.hnf-cure.org.

Visit MedFlash® on Facebook: http://www.facebook.com/pages/wwwmedflashcom/127476047265331?ref=ts

Follow MedFlash® on Twitter: http://twitter.com/MyMedFlash

About Connectyx Technologies Holdings Group Inc.

Connectyx Technologies provides unique products for the healthcare market including, MedFlash, the electronic Personal Health Manager (PHM). Compatible with Google Health and Microsoft's Health Vault, The MedFlash PHM is an easy to use Personal Health and Lifestyle Manager that is accessible using a powerful web portal suite. The MedFlash PHM also features a 24/7/365 call center, a USB flash drive and our (soon to be released) smart phone applications. The MedFlash PHM provides member benefits including instant access to your Emergency Medical Profile and Personal Health Record in the event of an accident or a medical emergency. Whether traveling, at work, or at home, First Responders have an invaluable advantage when they have access to this time critical information. Far more than just an emergency flash drive, The MedFlash PHM can be accessed on any computer, securely and with complete privacy. There are also lifestyle and wellness features that provide significant health benefits to members and risk mitigation for employers and insurers alike.

MedFlash members arrive at their Doctors offices with their paperwork pre-printed and ready to go. Insurance information and advance directives are available at a moment's notice through Instant Medical History, a leader in patient interview software and a MedFlash PHM technology partner. Prescriptions can also be listed for the physician's reference. Those are just a few of the time saving and risk mitigation features the MedFlash PHM provides. Connectyx products are developed with the needs of Patients, Families, Doctors and First Responders in mind. For more information, please visit our websites at: www.connectyx.com and www.medflash.com

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

SOURCE Connectyx Technologies Holdings Group, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Vigabatrin/CPP-109 Data to be Presented at College...
S
Frost & Sullivan Recognizes Excellence in Best Pra...